Contemporary treatment strategies for external pancreatic fistulas

Thomas Howard, Charles E. Stonerock, Jyoti Sarkar, Glen Lehman, Stuart Sherman, Eric A. Wiebke, James A. Madura, Thomas A. Broadie

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Background. Optimal treatment strategies for patients with external pancreatic fistulas have evolved with improved radiographic imaging and the development of transpapillary pancreatic duct stents. The aim of this study was to examine factors affecting fistula closure and develop a classification scheme to guide therapeutic interventions. Methods. Retrospective chart review was made of all patients with external pancreatic fistulas treated at our institution from January 1991 to January 1997. Side (partial) fistulas maintained continuity with the gastrointestinal tract; end (complete) fistulas had no continuity with the gastrointestinal tract. Results. Postoperative side fistulas resolved with medical treatment in 13 (86%)of 15 patients after a mean of 11 weeks of conservative management. Inflammatory side fistulas resolved with medical treatment in only 8 (53%) of 15 patients after a mean of 22 weeks; those that did not close initially did so with transpapillary stenting. End pancreatic fistulas never closed with medical treatment and were unable to be stented; therefore internal drainage or pancreatic resection was necessary to achieve closure. There were no differences in sepsis rates, Acute Physiology and Chronic Health Evaluation II scores, fistula site, total parenteral nutrition, somatostatin treatment, or initial fistula output between groups. Conclusions. Classifying external pancreatic fistulas as to their pancreatic duct relationship and cause provides important prognostic and therapeutic information.

Original languageEnglish (US)
Pages (from-to)627-633
Number of pages7
JournalSurgery
Volume124
Issue number4
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Cutaneous Fistula
Pancreatic Fistula
Fistula
Pancreatic Ducts
Therapeutics
Gastrointestinal Tract
APACHE
Total Parenteral Nutrition
Somatostatin
Stents
Drainage
Sepsis

ASJC Scopus subject areas

  • Surgery

Cite this

Contemporary treatment strategies for external pancreatic fistulas. / Howard, Thomas; Stonerock, Charles E.; Sarkar, Jyoti; Lehman, Glen; Sherman, Stuart; Wiebke, Eric A.; Madura, James A.; Broadie, Thomas A.

In: Surgery, Vol. 124, No. 4, 1998, p. 627-633.

Research output: Contribution to journalArticle

Howard, T, Stonerock, CE, Sarkar, J, Lehman, G, Sherman, S, Wiebke, EA, Madura, JA & Broadie, TA 1998, 'Contemporary treatment strategies for external pancreatic fistulas', Surgery, vol. 124, no. 4, pp. 627-633. https://doi.org/10.1067/msy.1998.91267
Howard, Thomas ; Stonerock, Charles E. ; Sarkar, Jyoti ; Lehman, Glen ; Sherman, Stuart ; Wiebke, Eric A. ; Madura, James A. ; Broadie, Thomas A. / Contemporary treatment strategies for external pancreatic fistulas. In: Surgery. 1998 ; Vol. 124, No. 4. pp. 627-633.
@article{7032047db2af458486d6b770f2c17e18,
title = "Contemporary treatment strategies for external pancreatic fistulas",
abstract = "Background. Optimal treatment strategies for patients with external pancreatic fistulas have evolved with improved radiographic imaging and the development of transpapillary pancreatic duct stents. The aim of this study was to examine factors affecting fistula closure and develop a classification scheme to guide therapeutic interventions. Methods. Retrospective chart review was made of all patients with external pancreatic fistulas treated at our institution from January 1991 to January 1997. Side (partial) fistulas maintained continuity with the gastrointestinal tract; end (complete) fistulas had no continuity with the gastrointestinal tract. Results. Postoperative side fistulas resolved with medical treatment in 13 (86{\%})of 15 patients after a mean of 11 weeks of conservative management. Inflammatory side fistulas resolved with medical treatment in only 8 (53{\%}) of 15 patients after a mean of 22 weeks; those that did not close initially did so with transpapillary stenting. End pancreatic fistulas never closed with medical treatment and were unable to be stented; therefore internal drainage or pancreatic resection was necessary to achieve closure. There were no differences in sepsis rates, Acute Physiology and Chronic Health Evaluation II scores, fistula site, total parenteral nutrition, somatostatin treatment, or initial fistula output between groups. Conclusions. Classifying external pancreatic fistulas as to their pancreatic duct relationship and cause provides important prognostic and therapeutic information.",
author = "Thomas Howard and Stonerock, {Charles E.} and Jyoti Sarkar and Glen Lehman and Stuart Sherman and Wiebke, {Eric A.} and Madura, {James A.} and Broadie, {Thomas A.}",
year = "1998",
doi = "10.1067/msy.1998.91267",
language = "English (US)",
volume = "124",
pages = "627--633",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Contemporary treatment strategies for external pancreatic fistulas

AU - Howard, Thomas

AU - Stonerock, Charles E.

AU - Sarkar, Jyoti

AU - Lehman, Glen

AU - Sherman, Stuart

AU - Wiebke, Eric A.

AU - Madura, James A.

AU - Broadie, Thomas A.

PY - 1998

Y1 - 1998

N2 - Background. Optimal treatment strategies for patients with external pancreatic fistulas have evolved with improved radiographic imaging and the development of transpapillary pancreatic duct stents. The aim of this study was to examine factors affecting fistula closure and develop a classification scheme to guide therapeutic interventions. Methods. Retrospective chart review was made of all patients with external pancreatic fistulas treated at our institution from January 1991 to January 1997. Side (partial) fistulas maintained continuity with the gastrointestinal tract; end (complete) fistulas had no continuity with the gastrointestinal tract. Results. Postoperative side fistulas resolved with medical treatment in 13 (86%)of 15 patients after a mean of 11 weeks of conservative management. Inflammatory side fistulas resolved with medical treatment in only 8 (53%) of 15 patients after a mean of 22 weeks; those that did not close initially did so with transpapillary stenting. End pancreatic fistulas never closed with medical treatment and were unable to be stented; therefore internal drainage or pancreatic resection was necessary to achieve closure. There were no differences in sepsis rates, Acute Physiology and Chronic Health Evaluation II scores, fistula site, total parenteral nutrition, somatostatin treatment, or initial fistula output between groups. Conclusions. Classifying external pancreatic fistulas as to their pancreatic duct relationship and cause provides important prognostic and therapeutic information.

AB - Background. Optimal treatment strategies for patients with external pancreatic fistulas have evolved with improved radiographic imaging and the development of transpapillary pancreatic duct stents. The aim of this study was to examine factors affecting fistula closure and develop a classification scheme to guide therapeutic interventions. Methods. Retrospective chart review was made of all patients with external pancreatic fistulas treated at our institution from January 1991 to January 1997. Side (partial) fistulas maintained continuity with the gastrointestinal tract; end (complete) fistulas had no continuity with the gastrointestinal tract. Results. Postoperative side fistulas resolved with medical treatment in 13 (86%)of 15 patients after a mean of 11 weeks of conservative management. Inflammatory side fistulas resolved with medical treatment in only 8 (53%) of 15 patients after a mean of 22 weeks; those that did not close initially did so with transpapillary stenting. End pancreatic fistulas never closed with medical treatment and were unable to be stented; therefore internal drainage or pancreatic resection was necessary to achieve closure. There were no differences in sepsis rates, Acute Physiology and Chronic Health Evaluation II scores, fistula site, total parenteral nutrition, somatostatin treatment, or initial fistula output between groups. Conclusions. Classifying external pancreatic fistulas as to their pancreatic duct relationship and cause provides important prognostic and therapeutic information.

UR - http://www.scopus.com/inward/record.url?scp=0031715015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031715015&partnerID=8YFLogxK

U2 - 10.1067/msy.1998.91267

DO - 10.1067/msy.1998.91267

M3 - Article

C2 - 9780981

AN - SCOPUS:0031715015

VL - 124

SP - 627

EP - 633

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 4

ER -